As a cornerstone biomarker for diabetes management, elevated HbA1c levels reflect chronic hyperglycemia that fosters a prothrombotic state through inflammatory pathways and impaired fibrinolysis, particularly via upregulation of plasminogen activator inhibitor-1 (PAI-1) (27, 28). Here, SERPINE1 is linked to diabetes mellitus.